North America extended its dominance for artificial intelligence (AI) hiring among pharmaceutical industry companies in the three months ending June.
The number of roles in North America made up 53.2% of total AI jobs – up from 47.6% in the same quarter last year.
Go deeper with GlobalData
That was followed by Asia-Pacific, which saw a 0.9 year-on-year percentage point change in AI roles.
The figures are compiled by GlobalData, who track the number of new job postings from key companies in various sectors over time. Using textual analysis, these job advertisements are then classified thematically.
GlobalData's thematic approach to sector activity seeks to group key company information by topic to see which companies are best placed to weather the disruptions coming to their industries.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThese key themes, which include artificial intelligence, are chosen to cover "any issue that keeps a CEO awake at night".
By tracking them across job advertisements it allows us to see which companies are leading the way on specific issues and which are dragging their heels - and importantly where the market is expanding and contracting.
Which countries are seeing the most growth for AI job ads in the pharmaceutical industry?
The fastest growing country was the United States, which saw 46.1% of all AI job adverts in the three months ending June 2021, increasing to 51.2% in the three months ending June this year.
That was followed by India (up 3.8 percentage points), Canada (0.6), and France (0.2).
The top country for AI roles in the pharmaceutical industry is the United States which saw 51.2% of all roles advertised in the three months ending June.
Which cities and locations are the biggest hubs for AI workers in the pharmaceutical industry?
Some 3.9% of all pharmaceutical industry AI roles were advertised in Bengaluru (India) in the three months ending June.
That was followed by Cambridge (United States) with 3.7%, Boston (United States) with 2.7%, and Durham (United States) with 2.6%.
